3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
5
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Multiple Myeloma
1
Melanoma, Cutaneous Malignant
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Glioblastoma
1
Gastroesophageal Cancer
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Cyclophosphamide
17
Rituximab
14
fludarabine phosphate
8
fludarabine
8
Specimen Handling
8
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
X-Rays
6
Prednisone
6
Phantoms, Imaging
6
Biopsy
6
polatuzumab vedotin
5
ibrutinib
5
Whole-Body Irradiation
5
Nuclear Medicine Department, Hospital
5
Mycophenolic Acid
5
Melphalan
5
Lenalidomide
5
Etoposide
5
Cyclosporine
5
venetoclax
4
tocilizumab
4
Doxorubicin
4
Busulfan
4
pembrolizumab
3
glofitamab
3
acalabrutinib
3
Vincristine
3
Tacrolimus
3
Sirolimus
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
relatlimab
×
30 days
×
Clear all
No trials found.